Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Short-term Investments (2018 - 2025)

Health Catalyst (HCAT) has disclosed Short-term Investments for 8 consecutive years, with $51.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Short-term Investments fell 13.06% year-over-year to $51.2 million, compared with a TTM value of $51.2 million through Sep 2025, down 13.06%, and an annual FY2024 reading of $142.4 million, down 32.68% over the prior year.
  • Short-term Investments was $51.2 million for Q3 2025 at Health Catalyst, up from $46.6 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $255.9 million in Q3 2022 and bottomed at $46.6 million in Q2 2025.
  • Average Short-term Investments over 5 years is $168.2 million, with a median of $195.4 million recorded in 2021.
  • The sharpest move saw Short-term Investments plummeted 76.84% in 2021, then skyrocketed 292.58% in 2022.
  • Year by year, Short-term Investments stood at $251.8 million in 2021, then fell by 1.82% to $247.2 million in 2022, then fell by 14.45% to $211.5 million in 2023, then tumbled by 32.68% to $142.4 million in 2024, then tumbled by 64.01% to $51.2 million in 2025.
  • Business Quant data shows Short-term Investments for HCAT at $51.2 million in Q3 2025, $46.6 million in Q2 2025, and $142.4 million in Q4 2024.